Health
Surface testing for SARS-CoV2 in hematology/oncology settings reveals negligible detection – EurekAlert
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency…
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces…
-
Noosa News20 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
General24 hours agoNZ PM wants united trade bloc-EU response to tariffs
-
Noosa News22 hours agoWoman allegedly tackled and assaulted by a man at Peregian Beach
-
General19 hours agoTed O’Brien was all over Chris Bowen like a wind turbine on an endangered bird